Application of Multifunctional Targeting Epirubicin Liposomes in the Treatment of Non-Small-Cell Lung Cancer [Corrigendum]

This article refers to:

Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer

Song X, Ju R, Xiao Y, et al. Int J Nanomedicine. 2017;12:7433‒7451.

The authors have advised due to an error at the time of figure assembly, Figure 5 on page 7442 is incorrect. The correct Figure 5 is shown below.

Figure 5 Destructive effects on VM channels and blocking effects on LL T cells migration in vitro after treatment with varying formulations.

Notes: (A) Destructive effects on VM channels, Magnification ×100. (B) blocking effects on LLT cells migration. Magnification ×100. a.Blank control; b.epirubicin liposomes; c.epirubicin plus honokiol liposomes; d.OCT-modified epirubicin liposomes; e.multifunctional targeting epirubicin liposomes.Abbreviations: LL T, Lewis lung tumor; OCT, octreotide; VM, vasculogenic mimicry.

The authors apologize for this error and advise it does not affect the results of the paper.